Immutep (IMMP) Income from Continuing Operations (2011 - 2024)
Immutep (IMMP) posted Income from Continuing Operations of 17275332.78 for Q4 2024, up 43.7% on a QoQ basis from 30682156.16 in Q2 2024, and down 14.74% year-over-year from 20261991.88 in Q1 2024.
Immutep (IMMP) Income from Continuing Operations (2011 - 2024) Analysis & Trends
Immutep's Income from Continuing Operations history runs 12 years deep, the most recent figure standing at 17275332.78 for Q4 2024.
- Quarterly Income from Continuing Operations fell 14.74% year-over-year to 17275332.78 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 77097475.37 (down 67.05% YoY) and the FY2025 annual result came in at 39344479.08, down 35.26% from the prior year.
- Income from Continuing Operations was 17275332.78 for Q4 2024 at Immutep, up from 30682156.16 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 12275506.91 in Q4 2021 and bottomed at 30682156.16 in Q2 2024.
- A 4-year average of 17874596.46 and a median of 15056041.44 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations decreased 6.9% — and 2024, when it retreated 14.74%.
- Immutep's Income from Continuing Operations stood at 12275506.91 in 2021, then slipped by 14.73% to 14083945.0 in 2022, then declined by 6.9% to 15056041.44 in 2023, then fell by 14.74% to 17275332.78 in 2024.
- Business Quant data shows IMMP's Income from Continuing Operations at 17275332.78 in Q4 2024, 30682156.16 in Q2 2024, and 15056041.44 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -17.28 Mn |
| Jun 30, 2024 | -30.68 Mn |
| Dec 31, 2023 | -15.06 Mn |
| Dec 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | -12.28 Mn |
| Dec 31, 2019 | -4.74 Mn |
| Jun 30, 2019 | -14.15 Mn |
| Dec 31, 2018 | -7.17 Mn |
| Jun 30, 2017 | -1.99 Mn |
| Mar 31, 2017 | -1.80 Mn |
| Dec 31, 2016 | -3.51 Mn |
| Jun 30, 2016 | -1.77 Mn |
| Mar 31, 2016 | -1.99 Mn |
| Jun 30, 2015 | -4.98 Bn |
| Jun 30, 2014 | -12.42 Mn |
| Dec 31, 2012 | -8.20 Mn |
| Jun 30, 2011 | -22.38 Mn |